Sustained osteoblast nuclear receptor binding of converted 1α,25- dihydroxyvitamin D3 after administration of 3H-1α-hydroxyvitamin D3: A combined receptor autoradiography and radioassay time course study with comparison to 3H-1α,25-dihydroxyvitamin D3

Calcified Tissue International

Volumn 63, Issue 5, 1998, Pages 391-395

  Koike, N ^a   Ichikawa, F ^a   Nishii, Y ^a   Stumpf, W E ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bone; Osteoporosis; Receptor binding; Therapy; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CELL NUCLEUS RECEPTOR; TRITIUM;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOBLAST; PRIORITY JOURNAL; RADIOASSAY; RAT;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BONE AND BONES; CALCITRIOL; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROXYCHOLECALCIFEROLS; KINETICS; MALE; OSTEOBLASTS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; TRITIUM;

EID: 0031670963     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900546     Document Type: Article

References (23)

1. Ponchon G, Kennan AL, DeLuca HF (1969) Activation of vitamin D by the liver. J Clin Invest 48:2032-2037
2. Lawson DE, Fraser DR, Kodicek E, Morris HR, Williams DH (1971) Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230: 228-230
3. 3 in chronic renal failure. Kidney Int 33:1049-1058
4. 3. J Am Chem Soc 95:2748-2749
5. 3. Science 180:190-191
6. Takuo F (1992) Minireview: vitamin D in the treatment of osteoporosis. Proc Soc Exp Biol Med 199:394-399
7. Civitelli R (1995) The role of vitamin D metabolites in the treatment of osteoporosis. Calcif Tissue Int 57:409-414
8. 3. J Biol Chem 256:7738-7740
9. 3. Bone 16:129-135
10. Stumpf WE (1976) Techniques for the autoradiography of diffusible compounds. Methods Cell Biol 13:171-193
11. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206: 1188-1190
12. 3 sites of action in the brain. An autoradiographic study. Histochemistry 87:393-406
13. Stumpf WE (1995) Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting. Histochem Cell Biol 104:417-427
14. 3 in bone from fetal rats. Calcif Tissue Int 35:177-182
15. 3 in developing rodent teeth: an autoradiographic study. Anat Rec 212:301-306
16. 3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification. Histochemistry 102:183-194
17. 3. Biochem Biophys Res Commun 97: 1031-1037
18. 3 with its chick internal receptor system. J Biol Chem 250: 8382-8388
19. Kanis JA, Russell RGG (1977) Rate of reversal of hypercalcemia and hypercalciurea induced by vitamin D and its 1α-hydroxylated derivatives. Br Med J 1:78-81
20. 3 in normal men. Bone Miner 2:479-485
21. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370-376
22. Lidor C, Sagiv P, Amdur B, Gepstein R, Otremski I, Hallel T, Edelstein S (1993) Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int 52:146-148
23. 3 analogues for the treatment of osteoporosis. Osteoporosis Int (suppl)1:190-193